Hirtle Callaghan & Co’s Booz Allen Hamilton BAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-256
Closed -$10K 156
2017
Q3
$10K Hold
256
﹤0.01% 176
2017
Q2
$8K Sell
256
-64
-20% -$2.3K ﹤0.01% 175
2017
Q1
$12K Hold
320
﹤0.01% 168
2016
Q4
$12K Sell
320
-172
-35% -$5.83K ﹤0.01% 132
2016
Q3
$16K Hold
492
﹤0.01% 179
2016
Q2
$15K Sell
492
-1,625
-77% -$46.5K ﹤0.01% 156
2016
Q1
$65K Sell
2,117
-169
-7% -$4.82K 0.01% 125
2015
Q4
$71K Hold
2,286
0.02% 111
2015
Q3
$58K Hold
2,286
0.01% 150
2015
Q2
$58K Buy
+2,286
New +$62K 0.02% 153
2015
Q1
Sell
-23
Closed -$1K 47
2014
Q4
$1K Buy
+23
New +$597 ﹤0.01% 522

Other funds holding BAH

Hirtle Callaghan & Co's BAH Position: Q4 2017 in Review

Hirtle Callaghan & Co sold out of Booz Allen Hamilton (BAH) in Q4 2017, closing a stake of 256 shares — an estimated $10K sold.

Hirtle Callaghan & Co first reported a position in BAH in Q4 2014 and held it in 11 quarters. The position peaked at $71K in Q4 2015. 269 funds tracked by Wall St. Rank hold BAH as of Q4 2017.

  • Hirtle Callaghan & Co reported no remaining Booz Allen Hamilton position as of Q4 2017 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 256 Booz Allen Hamilton shares in Q4 2017, an estimated $10K.
  • Hirtle Callaghan & Co first reported a position in Booz Allen Hamilton in Q4 2014 and held it in 11 quarters.
  • Hirtle Callaghan & Co's Booz Allen Hamilton position peaked at $71K in Q4 2015.
  • 269 funds tracked by Wall St. Rank held Booz Allen Hamilton as of Q4 2017.

Based on Hirtle Callaghan & Co's 13F filing for Q4 2017, filed 17 Jan 2018.